www.varchev.com

Early movers: DRI, WBA, TWTR, DIS, T, AGN, WEN, SBUX, UAL, S & more

Rating:

12345
Loading...

Walgreens Boots Alliance — The drugstore chain operator beat forecasts by 3 cents a share, with adjusted quarterly profit of $1.31 per share. Revenue did miss estimates as Walgreens navigates a "challenging retail sales environment," but it said it is making progress in cutting costs and implementing other efficiencies.

Twitter — Twitter has won the online streaming rights to Thursday night National Football League games, according to a Bloomberg report.

Walt Disney — Chief Operating Officer Tom Staggs is departing the company. He had been seen as a likely successor to CEO Robert Iger, but is said to have made his decision after learning that Disney's board had decided to broaden a search for Iger's successor to include more candidates.

AT&T — Macquarie began coverage on the telecommunications company with an "outperform" rating, noting that AT&T is likely to achieve above-GDP growth over the next few years.

Starbucks — Starbucks is rated "buy" in new coverage at Evercore, pointing to the consistency of store growth and earnings. The firm thinks the coffee chain can grow earnings at 17 percent annually through 2020.

Wendy's — Evercore began coverage on the restaurant chain with a "buy" rating, saying its streamlining effort has made substantial progress.

Constellation Brands — Wells Fargo rates the spirits maker "outperform" in new coverage, saying it is positioned to be a leading consumer staples company for years to come.

Tesla Motors — Tesla sold 14,820 vehicles during the first quarter, up 50 percent from a year earlier but a lower number than had been expected. The automaker's output was slowed in part by supplier shortages and what Tesla called its own "hubris in adding far too much new technology to the Model X."

Allergan — Allergan shares are under heavy pressure, following the announcement of new anti-inversion deal rules from the Treasury Department that could endanger its pending $160 million merger with Pfizer. For its part, Pfizer said it was reviewing the Treasury's actions and added that it would not speculate on any potential impact on the combination of the two drug makers.

United Continental — The airline reached a tentative five-year labor deal with 30,000 members of its machinists union. Workers will get a roughly 30 percent pay raise over the length of the contract, plus other benefits.

Valeant Pharmaceuticals — Valeant will cut the sales force for the female sexual dysfunction drug Addyi, as well as some dermatology products, according to a Reuters report which quotes an internal memo.

Dave & Buster's — The entertainment and arcade chain launched a 3.4 million share secondary offering on behalf of shareholder Oak Hill, according to a StreetAccount report.

Sprint — The mobile carrier struck a deal with Amazon which will allow customers to add the Amazon Prime service for an extra $10.99 per month. That adds up to more than Amazon Prime's $99 annual fee, but also allows customers the chance to stay or leave one month at a time.

Willis Towers Watson — The consulting firm now has Valueact Capital as a 5.9 percent stakeholder, according to a Securities and Exchange Commission filing. Valueact considers the shares undervalued and plans to have conversations with management about how to enhance shareholder value.


 Varchev Traders
RECCOMEND WAS THIS POST USEFUL FOR YOU?
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.
WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.
Varchev Finance

London


25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256

Universal numbers

World Financial Markets - 0700 17 600    Varchev Exchange - 0700 115 44

Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.

Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006

The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.


Disclaimer:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

chat with dealer
chat with dealer
Cookies policy